Clinical Trial Update: Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for Bemalenograstim Alfa in preventing outcomes for patients with colorectal or pancreatic cancer; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• Bemalenograstim Alfa (Bemalenograstim alfa)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Colorectal Cancer, Pancreatic Cancer | Phase 2 | Status: UNKNOWN